ENERGY FOCUS, INC/DE — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that ENERGY FOCUS, INC/DE filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.56M | Mar 24, 2026 |
| FY2025 | Dec 31, 2024 | $4.86M | Mar 24, 2026 |
| FY2024 | Dec 31, 2023 | $5.72M | Mar 25, 2025 |
| FY2022 | Dec 31, 2022 | $663.0K | Mar 23, 2023 |
| FY2022 | Sep 30, 2022 | $1.76M | Mar 23, 2023 |
| FY2022 | Jun 30, 2022 | $1.48M | Mar 23, 2023 |
| FY2022 | Mar 31, 2022 | $2.06M | Mar 23, 2023 |
| FY2022 | Dec 31, 2021 | $2.41M | Mar 23, 2023 |
| FY2022 | Sep 30, 2021 | $2.75M | Mar 23, 2023 |
| FY2022 | Jun 30, 2021 | $2.07M | Mar 23, 2023 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $4.73M | Feb 22, 2018 |
| FY2017 | Sep 30, 2017 | $5.00M | Feb 22, 2018 |
| FY2017 | Jun 30, 2017 | $6.01M | Feb 22, 2018 |
| FY2017 | Mar 31, 2017 | $4.11M | Feb 22, 2018 |
| FY2017 | Dec 31, 2016 | $7.19M | Feb 22, 2018 |
| FY2017 | Sep 30, 2016 | $8.26M | Feb 22, 2018 |
| FY2017 | Jun 30, 2016 | $7.13M | Feb 22, 2018 |
| FY2017 | Mar 31, 2016 | $8.43M | Feb 22, 2018 |
| FY2016 | Dec 31, 2015 | $17.25M | Feb 23, 2017 |
| FY2016 | Sep 30, 2015 | $18.34M | Feb 23, 2017 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $672.0K | Mar 24, 2026 |
| FY2025 | Dec 31, 2024 | $699.0K | Mar 24, 2026 |
| FY2024 | Dec 31, 2023 | $223.0K | Mar 25, 2025 |
| FY2022 | Dec 31, 2022 | ($238.0K) | Mar 23, 2023 |
| FY2022 | Sep 30, 2022 | ($163.0K) | Mar 23, 2023 |
| FY2022 | Jun 30, 2022 | $109.0K | Mar 23, 2023 |
| FY2022 | Mar 31, 2022 | ($26.0K) | Mar 23, 2023 |
| FY2022 | Dec 31, 2021 | $189.0K | Mar 23, 2023 |
| FY2022 | Sep 30, 2021 | $563.0K | Mar 23, 2023 |
| FY2022 | Jun 30, 2021 | $393.0K | Mar 23, 2023 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($1.03M) | Mar 24, 2026 |
| FY2025 | Dec 31, 2024 | ($1.58M) | Mar 24, 2026 |
| FY2024 | Dec 31, 2023 | ($4.29M) | Mar 25, 2025 |
| FY2022 | Dec 31, 2022 | ($2.31M) | Mar 23, 2023 |
| FY2022 | Sep 30, 2022 | ($2.66M) | Mar 23, 2023 |
| FY2022 | Jun 30, 2022 | ($2.49M) | Mar 23, 2023 |
| FY2022 | Mar 31, 2022 | ($2.82M) | Mar 23, 2023 |
| FY2022 | Dec 31, 2021 | ($2.63M) | Mar 23, 2023 |
| FY2022 | Sep 30, 2021 | ($1.14M) | Mar 23, 2023 |
| FY2022 | Jun 30, 2021 | ($2.47M) | Mar 23, 2023 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($1.02M) | Mar 24, 2026 |
| FY2025 | Dec 31, 2024 | ($1.84M) | Mar 24, 2026 |
| FY2024 | Dec 31, 2023 | ($3.97M) | Mar 25, 2025 |
| FY2023 | Dec 31, 2022 | ($9.30M) | Mar 22, 2024 |
| FY2022 | Dec 31, 2021 | ($8.71M) | Mar 23, 2023 |
| FY2021 | Dec 31, 2020 | ($4.07M) | Mar 17, 2022 |
| FY2020 | Dec 31, 2019 | ($6.96M) | Mar 25, 2021 |
| FY2019 | Dec 31, 2018 | ($9.09M) | Mar 24, 2020 |
| FY2019 | Dec 31, 2017 | ($11.28M) | Mar 24, 2020 |
| FY2018 | Dec 31, 2016 | ($16.83M) | Apr 1, 2019 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $412.0K | Mar 24, 2026 |
| FY2025 | Dec 31, 2024 | $524.0K | Mar 24, 2026 |
| FY2024 | Dec 31, 2023 | $587.0K | Mar 25, 2025 |
| FY2023 | Dec 31, 2022 | $1.49M | Mar 22, 2024 |
| FY2022 | Dec 31, 2021 | $1.89M | Mar 23, 2023 |
| FY2021 | Dec 31, 2020 | $1.42M | Mar 17, 2022 |
| FY2020 | Dec 31, 2019 | $1.28M | Mar 25, 2021 |
| FY2019 | Dec 31, 2018 | $2.60M | Mar 24, 2020 |
| FY2019 | Dec 31, 2017 | $2.94M | Mar 24, 2020 |
| FY2018 | Dec 31, 2016 | $3.54M | Apr 1, 2019 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.28M | Mar 24, 2026 |
| FY2025 | Dec 31, 2024 | $2.02M | Mar 24, 2026 |
| FY2024 | Dec 31, 2023 | $3.61M | Mar 25, 2025 |
| FY2023 | Dec 31, 2022 | $7.15M | Mar 22, 2024 |
| FY2022 | Dec 31, 2021 | $8.54M | Mar 23, 2023 |
| FY2021 | Dec 31, 2020 | $7.90M | Mar 17, 2022 |
| FY2020 | Dec 31, 2019 | $7.45M | Mar 25, 2021 |
| FY2019 | Dec 31, 2018 | $9.79M | Mar 24, 2020 |
| FY2019 | Dec 31, 2017 | $11.32M | Mar 24, 2020 |
| FY2018 | Dec 31, 2016 | $20.11M | Apr 1, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($1.40M) | Mar 24, 2026 |
| FY2025 | Dec 31, 2024 | ($1.30M) | Mar 24, 2026 |
| FY2024 | Dec 31, 2023 | ($2.44M) | Mar 25, 2025 |
| FY2023 | Dec 31, 2022 | ($6.71M) | Mar 22, 2024 |
| FY2022 | Dec 31, 2021 | ($9.77M) | Mar 23, 2023 |
| FY2021 | Dec 31, 2020 | ($2.45M) | Mar 17, 2022 |
| FY2020 | Dec 31, 2019 | ($6.62M) | Mar 25, 2021 |
| FY2019 | Dec 31, 2018 | ($6.80M) | Mar 24, 2020 |
| FY2019 | Dec 31, 2017 | ($5.87M) | Mar 24, 2020 |
| FY2014 | Dec 31, 2014 | ($1.43M) | Mar 12, 2015 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $54.0K | Mar 24, 2026 |
| FY2025 | Dec 31, 2024 | $19.0K | Mar 24, 2026 |
| FY2024 | Dec 31, 2023 | $69.0K | Mar 25, 2025 |
| FY2023 | Dec 31, 2022 | $41.0K | Mar 22, 2024 |
| FY2022 | Dec 31, 2021 | $443.0K | Mar 23, 2023 |
| FY2021 | Dec 31, 2020 | $223.0K | Mar 17, 2022 |
| FY2020 | Dec 31, 2019 | $132.0K | Mar 25, 2021 |
| FY2019 | Dec 31, 2018 | $57.0K | Mar 24, 2020 |
| FY2019 | Dec 31, 2017 | $162.0K | Mar 24, 2020 |
| FY2018 | Dec 31, 2016 | $1.62M | Apr 1, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.11M | Mar 24, 2026 |
| FY2025 | Dec 31, 2024 | $5.61M | Mar 24, 2026 |
| FY2024 | Dec 31, 2023 | $10.20M | Mar 25, 2025 |
| FY2023 | Dec 31, 2022 | $8.50M | Mar 22, 2024 |
| FY2022 | Dec 31, 2021 | $14.39M | Mar 23, 2023 |
| FY2021 | Dec 31, 2020 | $12.40M | Mar 17, 2022 |
| FY2020 | Dec 31, 2019 | $11.74M | Mar 25, 2021 |
| FY2019 | Dec 31, 2018 | $18.49M | Mar 24, 2020 |
| FY2018 | Dec 31, 2017 | $22.15M | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | $34.98M | Feb 22, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.00M | Mar 24, 2026 |
| FY2025 | Dec 31, 2024 | $2.70M | Mar 24, 2026 |
| FY2024 | Dec 31, 2023 | $7.15M | Mar 25, 2025 |
| FY2023 | Dec 31, 2022 | $8.98M | Mar 22, 2024 |
| FY2022 | Dec 31, 2021 | $8.18M | Mar 23, 2023 |
| FY2021 | Dec 31, 2020 | $8.14M | Mar 17, 2022 |
| FY2020 | Dec 31, 2019 | $7.74M | Mar 25, 2021 |
| FY2019 | Dec 31, 2018 | $7.44M | Mar 24, 2020 |
| FY2018 | Dec 31, 2017 | $2.86M | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | $5.04M | Feb 22, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.11M | Mar 24, 2026 |
| FY2025 | Dec 31, 2024 | $2.92M | Mar 24, 2026 |
| FY2025 | Dec 31, 2023 | $3.05M | Mar 24, 2026 |
| FY2024 | Dec 31, 2022 | ($477.0K) | Mar 25, 2025 |
| FY2023 | Nov 16, 2022 | $2.50M | Mar 22, 2024 |
| FY2022 | Nov 10, 2022 | $1.50M | Mar 23, 2023 |
| FY2023 | Sep 30, 2022 | $1.50M | Mar 22, 2024 |
| FY2023 | Dec 31, 2021 | $6.21M | Mar 22, 2024 |
| FY2022 | Dec 31, 2020 | $4.26M | Mar 23, 2023 |
| FY2021 | Jun 30, 2020 | $1.71M | Mar 17, 2022 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2011 | Dec 31, 2011 | $672.0K | Mar 30, 2012 |
| FY2011 | Dec 31, 2010 | $672.0K | Mar 30, 2012 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($155.92M) | Mar 24, 2026 |
| FY2025 | Dec 31, 2024 | ($154.90M) | Mar 24, 2026 |
| FY2024 | Dec 31, 2023 | ($153.32M) | Mar 25, 2025 |
| FY2023 | Dec 31, 2022 | ($149.02M) | Mar 22, 2024 |
| FY2022 | Dec 31, 2021 | ($138.74M) | Mar 23, 2023 |
| FY2021 | Dec 31, 2020 | ($130.86M) | Mar 17, 2022 |
| FY2020 | Dec 31, 2019 | ($124.87M) | Mar 25, 2021 |
| FY2019 | Dec 31, 2018 | ($117.32M) | Mar 24, 2020 |
| FY2018 | Dec 31, 2017 | ($108.20M) | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | ($96.94M) | Feb 22, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.06M | Mar 24, 2026 |
| FY2025 | Dec 31, 2024 | $565.0K | Mar 24, 2026 |
| FY2024 | Dec 31, 2023 | $2.03M | Mar 25, 2025 |
| FY2023 | Dec 31, 2022 | $52.0K | Mar 22, 2024 |
| FY2022 | Dec 31, 2021 | $2.68M | Mar 23, 2023 |
| FY2021 | Dec 31, 2020 | $1.84M | Mar 17, 2022 |
| FY2020 | Dec 31, 2019 | $350.0K | Mar 25, 2021 |
| FY2019 | Dec 31, 2018 | $6.34M | Mar 24, 2020 |
| FY2019 | Dec 31, 2017 | $10.76M | Mar 24, 2020 |
| FY2019 | Dec 31, 2016 | $16.60M | Mar 24, 2020 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2015 | Dec 31, 2014 | $70.0K | Mar 10, 2016 |
| FY2014 | Dec 31, 2013 | $4.07M | Mar 12, 2015 |
| FY2013 | Dec 31, 2012 | $2.55M | Mar 27, 2014 |
| FY2012 | Dec 31, 2011 | $1.81M | Mar 27, 2013 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 24, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 24, 2026 |
| FY2022 | Dec 31, 2022 | 0 | Mar 23, 2023 |
| FY2022 | Sep 30, 2022 | 0 | Mar 23, 2023 |
| FY2022 | Jun 30, 2022 | 0 | Mar 23, 2023 |
| FY2022 | Mar 31, 2022 | 0 | Mar 23, 2023 |
| FY2022 | Dec 31, 2021 | 0 | Mar 23, 2023 |
| FY2022 | Sep 30, 2021 | 0 | Mar 23, 2023 |
| FY2022 | Jun 30, 2021 | 0 | Mar 23, 2023 |
| FY2022 | Mar 31, 2021 | 0 | Mar 23, 2023 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 24, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 24, 2026 |
| FY2022 | Dec 31, 2022 | 0 | Mar 23, 2023 |
| FY2022 | Sep 30, 2022 | 0 | Mar 23, 2023 |
| FY2022 | Jun 30, 2022 | 0 | Mar 23, 2023 |
| FY2022 | Mar 31, 2022 | 0 | Mar 23, 2023 |
| FY2022 | Dec 31, 2021 | 0 | Mar 23, 2023 |
| FY2022 | Sep 30, 2021 | 0 | Mar 23, 2023 |
| FY2022 | Jun 30, 2021 | 0 | Mar 23, 2023 |
| FY2022 | Mar 31, 2021 | 0 | Mar 23, 2023 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 6.31M | Mar 24, 2026 |
| FY2025 | Dec 31, 2024 | 5.26M | Mar 24, 2026 |
| FY2024 | Dec 31, 2023 | 4.35M | Mar 25, 2025 |
| FY2023 | Dec 31, 2022 | 1.41M | Mar 22, 2024 |
| FY2022 | Dec 31, 2021 | 6.37M | Mar 23, 2023 |
| FY2021 | Dec 31, 2020 | 3.53M | Mar 17, 2022 |
| FY2020 | Dec 31, 2019 | 2.49M | Mar 25, 2021 |
| FY2019 | Dec 31, 2018 | 12.09M | Mar 24, 2020 |
| FY2018 | Dec 31, 2017 | 11.87M | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | 11.71M | Feb 22, 2018 |